305 related articles for article (PubMed ID: 32397158)
1. The Role of Hyperglycemia in Endometrial Cancer Pathogenesis.
Byrne FL; Martin AR; Kosasih M; Caruana BT; Farrell R
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32397158
[TBL] [Abstract][Full Text] [Related]
2. Metformin as a Therapeutic Target in Endometrial Cancers.
Lee TY; Martinez-Outschoorn UE; Schilder RJ; Kim CH; Richard SD; Rosenblum NG; Johnson JM
Front Oncol; 2018; 8():341. PubMed ID: 30211120
[TBL] [Abstract][Full Text] [Related]
3. [Molecular action of insulin-sensitizing agents].
Kacalska O; Krzyczkowska-Sendrakowska M; Milewicz T; Zabińska-Popiela M; Bereza T; Krzysiek-Maczka G; Krzysiek J
Endokrynol Pol; 2005; 56(3):308-13. PubMed ID: 16350724
[TBL] [Abstract][Full Text] [Related]
4. The role of bariatric and metabolic surgery in the development, diagnosis, and treatment of endometrial cancer.
Ross RC; Akinde YM; Schauer PR; le Roux CW; Brennan D; Jernigan AM; Bueter M; Albaugh VL
Front Surg; 2022; 9():943544. PubMed ID: 36117808
[TBL] [Abstract][Full Text] [Related]
5. Obesity Epidemic-The Underestimated Risk of Endometrial Cancer.
Kiesel L; Eichbaum C; Baumeier A; Eichbaum M
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33371216
[TBL] [Abstract][Full Text] [Related]
6. Metabolic abnormalities (hypertension, hyperglycemia and overweight), lifestyle (high energy intake and physical inactivity) and endometrial cancer risk in a Norwegian cohort.
Furberg AS; Thune I
Int J Cancer; 2003 May; 104(6):669-76. PubMed ID: 12640672
[TBL] [Abstract][Full Text] [Related]
7. The Role of Obesity in the Etiology and Carcinogenesis of Endometrial Cancer.
Marin AG; Filipescu A; Petca A
Cureus; 2024 Apr; 16(4):e59219. PubMed ID: 38807790
[TBL] [Abstract][Full Text] [Related]
8. Diabetes, antihyperglycemic medications and cancer risk: smoke or fire?
Gallagher EJ; LeRoith D
Curr Opin Endocrinol Diabetes Obes; 2013 Oct; 20(5):485-94. PubMed ID: 23974779
[TBL] [Abstract][Full Text] [Related]
9. Does Bariatric Surgery Affect the Incidence of Endometrial Cancer Development? A Systematic Review.
Winder AA; Kularatna M; MacCormick AD
Obes Surg; 2018 May; 28(5):1433-1440. PubMed ID: 29512036
[TBL] [Abstract][Full Text] [Related]
10. Reversal of obesity-driven aggressiveness of endometrial cancer by metformin.
Guo H; Kong W; Zhang L; Han J; Clark LH; Yin Y; Fang Z; Sun W; Wang J; Gilliam TP; Lee D; Makowski L; Zhou C; Bae-Jump VL
Am J Cancer Res; 2019; 9(10):2170-2193. PubMed ID: 31720081
[TBL] [Abstract][Full Text] [Related]
11. Addressing the Role of Obesity in Endometrial Cancer Risk, Prevention, and Treatment.
Onstad MA; Schmandt RE; Lu KH
J Clin Oncol; 2016 Dec; 34(35):4225-4230. PubMed ID: 27903150
[TBL] [Abstract][Full Text] [Related]
12. Impaired glucose metabolism and diabetes and the risk of breast, endometrial, and ovarian cancer.
Lambe M; Wigertz A; Garmo H; Walldius G; Jungner I; Hammar N
Cancer Causes Control; 2011 Aug; 22(8):1163-71. PubMed ID: 21688131
[TBL] [Abstract][Full Text] [Related]
13. Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship.
Fader AN; Arriba LN; Frasure HE; von Gruenigen VE
Gynecol Oncol; 2009 Jul; 114(1):121-7. PubMed ID: 19406460
[TBL] [Abstract][Full Text] [Related]
14. Diabetes and Cancer: Cancer Should Be Screened in Routine Diabetes Assessment.
Suh S; Kim KW
Diabetes Metab J; 2019 Dec; 43(6):733-743. PubMed ID: 31902143
[TBL] [Abstract][Full Text] [Related]
15. The epidemiology and molecular mechanisms linking obesity, diabetes, and cancer.
Ferguson RD; Gallagher EJ; Scheinman EJ; Damouni R; LeRoith D
Vitam Horm; 2013; 93():51-98. PubMed ID: 23810003
[TBL] [Abstract][Full Text] [Related]
16. Diabetes mellitus and gynecologic cancer: molecular mechanisms, epidemiological, clinical and prognostic perspectives.
Vrachnis N; Iavazzo C; Iliodromiti Z; Sifakis S; Alexandrou A; Siristatidis C; Grigoriadis C; Botsis D; Creatsas G
Arch Gynecol Obstet; 2016 Feb; 293(2):239-46. PubMed ID: 26338721
[TBL] [Abstract][Full Text] [Related]
17. Metabolic syndrome and risk of endometrial cancer in postmenopausal women: a prospective study.
Arthur RS; Kabat GC; Kim MY; Wild RA; Shadyab AH; Wactawski-Wende J; Ho GYF; Reeves KW; Kuller LH; Luo J; Beebe-Dimmer J; Simon MS; Strickler H; Wassertheil-Smoller S; Rohan TE
Cancer Causes Control; 2019 Apr; 30(4):355-363. PubMed ID: 30788634
[TBL] [Abstract][Full Text] [Related]
18. Use of Metformin in Obese Women With Type I Endometrial Cancer Is Associated With a Reduced Incidence of Cancer Recurrence.
Hall C; Stone RL; Gehlot A; Zorn KK; Burnett AF
Int J Gynecol Cancer; 2016 Feb; 26(2):313-7. PubMed ID: 26588235
[TBL] [Abstract][Full Text] [Related]
19. The Role of Metabolic Syndrome in Endometrial Cancer: A Review.
Yang X; Wang J
Front Oncol; 2019; 9():744. PubMed ID: 31440472
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for endometrial cancer.
Ali AT
Ceska Gynekol; 2013 Nov; 78(5):448-59. PubMed ID: 24313431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
